Corrigendum to “comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix” [Gynecol. Oncol. 145 (2017) 284–290]

Kamran, Sophia C.; Manuel, Matthias M.; Cho, Linda P.; Damato, Antonio L.; Schmidt, Ehud J.; Tempany, Clare M.; Cormack, Robert A.; Viswanathan, Akila N.

doi:10.1016/j.ygyno.2017.05.035

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Brachytherapy, with a shift toward image-guided treatment delivery and an evolution of interstitial applicators, has seen a significant shift in the past decade 34. MRI is now recommended for image-guided adaptive brachytherapy to enable dose optimization and escalation with higher local control rates for large tumors and decreased rates of normal tissue toxicities 35 36…”

Section: Introductionmentioning

confidence: 99%

Radiation oncology management of stage III and IVA cervical carcinoma

Franco

Viswanathan

2022

Int J Gynecol Cancer

View full text Add to dashboard Cite

Worldwide, stage III–IVA carcinomas of the uterine cervix comprise a significant proportion of cases at presentation, and have a higher rate of recurrence and worse overall survival. This review will discuss the epidemiology, prevention strategies, clinical presentation, and treatment recommendations for stage III–IVA cervical cancer. The focus will be on the role of radiation therapy, concurrent chemoradiotherapy, and brachytherapy, including the potential benefits and anticipated toxicities. The unique challenges and considerations of fistula formation and approaches to management will be highlighted, and follow-up care and future directions discussed. As low and middle income countries bear the highest burden of advanced stage carcinoma of the uterine cervix, this review will address the unique needs of global communities.

show abstract

Section: Introductionmentioning

confidence: 99%